An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma.
Kim GP, Mahoney MR, Szydlo D, Mok TS, Marshke R, Holen K, Picus J, Boyer M, Pitot HC, Rubin J, Philip PA, Nowak A, Wright JJ, Erlichman C.
Kim GP, et al.
Invest New Drugs. 2012 Feb;30(1):387-94. doi: 10.1007/s10637-010-9532-1. Epub 2010 Sep 14.
Invest New Drugs. 2012.
PMID: 20839030
Free PMC article.
Clinical Trial.